A novel heterozygous frameshift c.277del p.Thr93Leufs21 mutation in SERPINC1 associated with type 1 antithrombin deficiency

被引：0
|
作者：
Kumar, Riten [1 ,2 ,4 ]
Duzan, Juliann [1 ]
Drake, Emily [1 ]
Dawson, Jennifer [3 ]
机构：
[1] Dana Farber Boston Childrens Canc & Blood Disorder, Boston, MA USA
[2] Harvard Med Sch, Dept Pediat, Boston, MA USA
[3] Cleveland Clin, Lerner Res Inst, Genom Med, Cleveland, OH USA
[4] Dana Farber Boston Childrens Canc & Blood Disorder, 300 Longwood Ave, Boston, MA 02115 USA
来源：
PEDIATRIC BLOOD & CANCER | 2024年 / 71卷 / 06期
关键词：
CHILDREN; THROMBOPHILIA; PREVALENCE; IMPACT; SET;
D O I：
10.1002/pbc.30986
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 45 条
  • [21] Novel SERPINC1 missense mutation (Cys462Tyr) causes disruption of the 279Cys-462Cys disulfide bond and leads to type I hereditary antithrombin deficiency
    Zhang, Fuyong
    Gui, Ying
    Lu, Yu
    Liu, Denghe
    Chen, Huaping
    Qin, Xue
    Li, Shan
    CLINICAL BIOCHEMISTRY, 2020, 85 : 38 - 42
  • [22] A novel mutation KCNQ1p.Thr312del is responsible for long QT syndrome type 1
    Xiao-Meng Chen
    Kai Guo
    Hong Li
    Qiu-Fen Lu
    Chao Yang
    Ying Yu
    Jian-Wen Hou
    Yu-Dong Fei
    Jian Sun
    Jun Wang
    Yi-Xue Li
    Yi-Gang Li
    Heart and Vessels, 2019, 34 : 177 - 188
  • [23] A novel mutation KCNQ1p.Thr312del is responsible for long QT syndrome type 1
    Chen, Xiao-Meng
    Guo, Kai
    Li, Hong
    Lu, Qiu-Fen
    Yang, Chao
    Yu, Ying
    Hou, Jian-Wen
    Fei, Yu-Dong
    Sun, Jian
    Wang, Jun
    Li, Yi-Xue
    Li, Yi-Gang
    HEART AND VESSELS, 2019, 34 (01) : 177 - 188
  • [24] Antithrombin Krakow II (c.624+1 G > T): a novel mutation leading to type 1 antithrombin deficiency
    Celinska-Loewenhoff, Magdalena
    Iwaniec, Teresa
    Alhenc-Gelas, Martine
    Musial, Jacek
    Undas, Anetta
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (05) : 454 - 455
  • [25] A novel SERPINC1 c.119G>A (p.Cys40Tyr) mutation with variable clinical expression in an Indian family
    Patil, Kranti
    Shah, Asha
    Saini, Gurpreet
    Tawde, Shreyas
    Kharat, Shruti
    Jivani, Fiza
    Kamble, Aniket
    Shetty, Shrimati
    BLOOD COAGULATION & FIBRINOLYSIS, 2024, 35 (08) : 379 - 381
  • [26] A novel type of mutation at the propeptide cleavage site (Ala+1Thr) causing symptomatic protein C type II deficiency
    Dodojacek, R
    Höfler, G
    Leschnik, B
    Muntean, W
    30TH HEMOPHILIA SYMPOSIUM, 2001, : 126 - 131
  • [27] A novel type of mutation at the propeptide cleavage site (AlA+1Thr) causing symptomatic protein C type II deficiency
    Dodojacek, R
    Höfler, G
    Leschnik, B
    Muntean, W
    THROMBOSIS RESEARCH, 2000, 100 (01) : 109 - 113
  • [28] SERPINC1 novel mutation (c.637C > T p. Gln213Ter) in a cerebral venous sinus thrombosis case and treatment with agatroban
    Ma, Hongrui
    Wu, Longfei
    Duan, Jiangang
    Ji, Xunming
    THROMBOSIS RESEARCH, 2021, 199 : 35 - 37
  • [29] A novel compound heterozygous mutation of the MTO1 gene associated with complex oxidative phosphorylation deficiency type 10
    Luo, Qing
    Wen, Xia
    Zhou, Jiahong
    Chen, Yang
    Lv, Zhiyu
    Shen, Xing
    Liu, Jinbo
    CLINICA CHIMICA ACTA, 2021, 523 : 172 - 177
  • [30] A novel missense mutation at the propeptide cleavage site (Ala+1 Thr) causing symptomatic protein C type II deficiency
    Dodojacek, R
    Muntean, W
    Hoefler, G
    THROMBOSIS AND HAEMOSTASIS, 1999, : 566 - 567
12345